Medical Affairs Lead, DACH

Job Summary

We are looking for a Medical Affairs Lead, who is responsible for shaping and delivering the DACH medical strategy, driving education, evidence generation, and engagement with healthcare professionals and key opinion leaders in the diabetes space. The role leads cross‑functional collaboration to support product launches, market access, and adoption of Insulet’s solutions. As part of the regional leadership team, they oversee Medical Affairs activities, manage a team, and ensure alignment with global and local objectives. This position requires deep scientific expertise, strong leadership, and experience in diabetes within pharma or medical devices.

Responsibilities

• Supervise country Medical Affairs staff focused on delivering the medical objectives for the region by providing direction, guidance and oversight of assigned projects and accountabilities
• Develop and lead the execution of the Medical Affairs strategy at a country level through cross‑functional collaboration and influence – supporting efficient go‑to‑market plans
• Lead, establish and execute the local medical education plans for the DACH: educate HCP with online/in‑person blended offerings (on‑demand, webinars, Peer‑to‑Peer training), deliver medical education at congresses and symposiums, support product training with generation and delivery of medical content
• Inform & strategize evidence generation plans, in answer to fulfil market access, regulatory and marketing needs
• Support the local execution of Insulet‑sponsored and Investigator‑Initiated trials
• Disseminate evidence
• Identify and engage with HCP to inform and seek advice on the company’s solutions, through the execution of advisory boards, clinical activity, scientific Exchange and educational Events
• Establish and maintain credible peer‑to‑peer scientific relationships with national and regional KOLs
• Build confidence and advocacy among key external influencers (KOLs)
• Build and share knowledge with internal and external stakeholders regarding the use and benefits of current and future Insulet products
• Work collaboratively with cross‑functional partners
• Translate clinical data into scientifically sound, tangible insights and claims
• Review and approve externally‑facing materials for scientific and medical accuracy
• Review scientific and medical content for externally‑facing content, using the Veeva system
• Answer HCP medical queries
• Assist with sales events such as pump clinics, pump support groups, info sessions, in‑the‑office educational events, patient info nights, advocacy events, etc.
• Maintain a thorough and detailed working knowledge of the organization and its products, current scientific research and publications
• Performs other duties as required
• Key Decision Rights
• Country Medical strategy, including launch plans; KOL engagement activity; Medical Education activities for the DACH

Education And Experience

• MD, PharmD, PhD or MS in life science or an equivalent
• 8 or more years of relevant or equivalent Medical Affairs experience in diabetes within the pharmaceutical or medical device industry
• In‑depth understanding of the diabetes disease state, the current/future treatment landscape, and ongoing clinical trials/research
• Understanding of the country medical practice and clinical decision‑making regarding patient care for diabetes

Skills/Competencies

• Proven leader in Medical Affairs including developing and leading the implementation of medical strategy.
• Excellent written and verbal communication skills in English
• Broad understanding of the international commercial and regulatory environment for medical devices
• Strong scientific acumen and attention to detail
• Combined strategic thinking and execution skills
• Demonstrated ability to integrate, lead and influence in a challenging cross‑functional environment.
• High ethical standards which apply to interactions with HCPs, payers, and industry representatives

Physical Requirements (if applicable)

• Location: Germany
• This role will involve frequent travel, approximately 40% mainly in the DACH region and within international region on occasions (conferences, medical education events, internal meetings).